Clinical Trials
142
17 active
Approvals
0
Total approvals
Agencies
0
Regulatory bodies
Founded
1958
Active, not recruiting
8
5.6%
Completed
80
56.3%
Enrolling By Invitation
3
2.1%
Not yet recruiting
6
4.2%
Recruiting
16
11.3%
Suspended
2
1.4%
Terminated
8
5.6%
Unknown
19
13.4%
No approval data available
- A University of Oulu study of 2,264 participants from the Northern Finland Birth Cohort 1966 found higher habitual coffee intake associated with lower total and visceral fat and greater skeletal muscle mass. - Higher coffee consumption correlated with lower circulating branched-chain amino acids, biomarkers linked to insulin resistance and type 2 diabetes risk. - The strongest sex-specific associations appeared in men, including a more favorable glucose-insulin profile and higher total and bioavailable testosterone. - As an observational study, the findings demonstrate associations rather than causation, providing a foundation for future mechanistic and intervention research.
- Finnish healthcare system has reduced multiple sclerosis diagnosis time from ten to five months, enabling earlier treatment initiation and improved patient outcomes. - Treatment protocols have shifted dramatically, with highly effective immunomodulating medications now being prescribed as first-line therapy instead of traditional moderate-efficacy drugs. - Despite COVID-19 pandemic challenges, Finland maintained consistent MS diagnosis and treatment timelines, demonstrating resilient healthcare delivery.
